Health Archives - Daily Startup Magazine

Home

Lucknow, Uttar Pradesh — In a landmark development for ophthalmic care in North India, Dr. Azad Gaurav has successfully performed the first iStent Inject® W procedure in Lucknow and the state of Uttar Pradesh at Prakash Netra Kendra, Lucknow. This milestone introduces a globally recognized, minimally invasive glaucoma surgery (MIGS) to patients in the region, offering a safer and more effective solution for early-stage glaucoma management.

The iStent Inject® W is an advanced micro-invasive implant designed to reduce intraocular pressure (IOP) by improving the eye’s natural fluid outflow. Particularly beneficial for patients with mild to moderate primary open-angle glaucoma (POAG), the procedure is performed through a minimally invasive approach, ensuring faster recovery, reduced surgical risk, and improved patient comfort.

This innovative treatment provides patients with the potential to significantly reduce—or even eliminate—their dependence on long-term anti-glaucoma medications, which are often associated with compliance challenges and side effects. Early intervention with iStent technology helps stabilize IOP and plays a critical role in preserving vision and preventing disease progression.

Globally, iStent technology has been widely adopted, with over 3 million implants performed worldwide.

Commenting on this achievement, Dr. Azad Gaurav said:

"The introduction of iStent Inject® W in Lucknow marks a new era in glaucoma management for our region. Early-stage glaucoma patients now have access to a minimally invasive option that not only controls IOP effectively but also reduces their dependence on lifelong medications. Our goal is to preserve vision with the least possible disruption to patients’ daily lives."

Adding to this, renowned glaucoma specialist Dr. Rajat Dhsai remarked:

"Micro-invasive glaucoma surgery, particularly with technologies like iStent Inject® W, is transforming the way we approach glaucoma treatment. It bridges the gap between medical therapy and conventional surgery, offering a safer and patient-friendly solution for early intervention. The adoption of such advanced technologies in cities like Lucknow is a significant step toward improving glaucoma outcomes across India."

The first patient treated with this technology at Prakash Netra Kendra has shown encouraging early outcomes, including stable intraocular pressure and reduced reliance on medications, underscoring the effectiveness of the procedure.

The successful introduction of iStent Inject® W at Prakash Netra Kendra reinforces the institution’s commitment to bringing world-class ophthalmic innovations to Uttar Pradesh. It also ensures that patients in Lucknow and surrounding regions can now access advanced glaucoma care without the need to travel to metropolitan centers.

About Prakash Netra Kendra

Prakash Netra Kendra, Lucknow, is a leading eye care center dedicated to delivering comprehensive and advanced ophthalmic services. With a focus on innovation, precision, and patient-centric care, the center continues to adopt the latest technologies to improve clinical outcomes and enhance patient quality of life.

Media Contact:
Prakash Netra Kendra
Gomti Nagar- NH-II, VipulKhand-IV, Gomtinagar, Lucknow 226010
pnk.tpa@gmail.com
info@pnkeyecare.com
0522 424 2164
About Us

Lucknow, Uttar Pradesh — In a landmark development for ophthalmic care in North India, Dr. Azad Gaurav has successfully performed the first iStent Inject® W procedure in Lucknow and the state of Uttar Pradesh at Prakash Netra Kendra, Lucknow. This milestone introduces a globally recognized, minimally invasive glaucoma surgery (MIGS) to patients in the region, offering a safer and more effective solution for early-stage glaucoma management.

The iStent Inject® W is an advanced micro-invasive implant designed to reduce intraocular pressure (IOP) by improving the eye’s natural fluid outflow. Particularly beneficial for patients with mild to moderate primary open-angle glaucoma (POAG), the procedure is performed through a minimally invasive approach, ensuring faster recovery, reduced surgical risk, and improved patient comfort.

This innovative treatment provides patients with the potential to significantly reduce—or even eliminate—their dependence on long-term anti-glaucoma medications, which are often associated with compliance challenges and side effects. Early intervention with iStent technology helps stabilize IOP and plays a critical role in preserving vision and preventing disease progression.

Globally, iStent technology has been widely adopted, with over 3 million implants performed worldwide.

Commenting on this achievement, Dr. Azad Gaurav said:

"The introduction of iStent Inject® W in Lucknow marks a new era in glaucoma management for our region. Early-stage glaucoma patients now have access to a minimally invasive option that not only controls IOP effectively but also reduces their dependence on lifelong medications. Our goal is to preserve vision with the least possible disruption to patients’ daily lives."

Adding to this, renowned glaucoma specialist Dr. Rajat Dhsai remarked:

"Micro-invasive glaucoma surgery, particularly with technologies like iStent Inject® W, is transforming the way we approach glaucoma treatment. It bridges the gap between medical therapy and conventional surgery, offering a safer and patient-friendly solution for early intervention. The adoption of such advanced technologies in cities like Lucknow is a significant step toward improving glaucoma outcomes across India."

The first patient treated with this technology at Prakash Netra Kendra has shown encouraging early outcomes, including stable intraocular pressure and reduced reliance on medications, underscoring the effectiveness of the procedure.

The successful introduction of iStent Inject® W at Prakash Netra Kendra reinforces the institution’s commitment to bringing world-class ophthalmic innovations to Uttar Pradesh. It also ensures that patients in Lucknow and surrounding regions can now access advanced glaucoma care without the need to travel to metropolitan centers.

About Prakash Netra Kendra

Prakash Netra Kendra, Lucknow, is a leading eye care center dedicated to delivering comprehensive and advanced ophthalmic services. With a focus on innovation, precision, and patient-centric care, the center continues to adopt the latest technologies to improve clinical outcomes and enhance patient quality of life.

Media Contact:
Prakash Netra Kendra
Gomti Nagar- NH-II, VipulKhand-IV, Gomtinagar, Lucknow 226010
pnk.tpa@gmail.com
info@pnkeyecare.com
0522 424 2164
Press Release

Lucknow, Uttar Pradesh — In a landmark development for ophthalmic care in North India, Dr. Azad Gaurav has successfully performed the first iStent Inject® W procedure in Lucknow and the state of Uttar Pradesh at Prakash Netra Kendra, Lucknow. This milestone introduces a globally recognized, minimally invasive glaucoma surgery (MIGS) to patients in the region, offering a safer and more effective solution for early-stage glaucoma management.

The iStent Inject® W is an advanced micro-invasive implant designed to reduce intraocular pressure (IOP) by improving the eye’s natural fluid outflow. Particularly beneficial for patients with mild to moderate primary open-angle glaucoma (POAG), the procedure is performed through a minimally invasive approach, ensuring faster recovery, reduced surgical risk, and improved patient comfort.

This innovative treatment provides patients with the potential to significantly reduce—or even eliminate—their dependence on long-term anti-glaucoma medications, which are often associated with compliance challenges and side effects. Early intervention with iStent technology helps stabilize IOP and plays a critical role in preserving vision and preventing disease progression.

Globally, iStent technology has been widely adopted, with over 3 million implants performed worldwide.

Commenting on this achievement, Dr. Azad Gaurav said:

"The introduction of iStent Inject® W in Lucknow marks a new era in glaucoma management for our region. Early-stage glaucoma patients now have access to a minimally invasive option that not only controls IOP effectively but also reduces their dependence on lifelong medications. Our goal is to preserve vision with the least possible disruption to patients’ daily lives."

Adding to this, renowned glaucoma specialist Dr. Rajat Dhsai remarked:

"Micro-invasive glaucoma surgery, particularly with technologies like iStent Inject® W, is transforming the way we approach glaucoma treatment. It bridges the gap between medical therapy and conventional surgery, offering a safer and patient-friendly solution for early intervention. The adoption of such advanced technologies in cities like Lucknow is a significant step toward improving glaucoma outcomes across India."

The first patient treated with this technology at Prakash Netra Kendra has shown encouraging early outcomes, including stable intraocular pressure and reduced reliance on medications, underscoring the effectiveness of the procedure.

The successful introduction of iStent Inject® W at Prakash Netra Kendra reinforces the institution’s commitment to bringing world-class ophthalmic innovations to Uttar Pradesh. It also ensures that patients in Lucknow and surrounding regions can now access advanced glaucoma care without the need to travel to metropolitan centers.

About Prakash Netra Kendra

Prakash Netra Kendra, Lucknow, is a leading eye care center dedicated to delivering comprehensive and advanced ophthalmic services. With a focus on innovation, precision, and patient-centric care, the center continues to adopt the latest technologies to improve clinical outcomes and enhance patient quality of life.

Media Contact:
Prakash Netra Kendra
Gomti Nagar- NH-II, VipulKhand-IV, Gomtinagar, Lucknow 226010
pnk.tpa@gmail.com
info@pnkeyecare.com
0522 424 2164
Lifestyle

Lucknow, Uttar Pradesh — In a landmark development for ophthalmic care in North India, Dr. Azad Gaurav has successfully performed the first iStent Inject® W procedure in Lucknow and the state of Uttar Pradesh at Prakash Netra Kendra, Lucknow. This milestone introduces a globally recognized, minimally invasive glaucoma surgery (MIGS) to patients in the region, offering a safer and more effective solution for early-stage glaucoma management.

The iStent Inject® W is an advanced micro-invasive implant designed to reduce intraocular pressure (IOP) by improving the eye’s natural fluid outflow. Particularly beneficial for patients with mild to moderate primary open-angle glaucoma (POAG), the procedure is performed through a minimally invasive approach, ensuring faster recovery, reduced surgical risk, and improved patient comfort.

This innovative treatment provides patients with the potential to significantly reduce—or even eliminate—their dependence on long-term anti-glaucoma medications, which are often associated with compliance challenges and side effects. Early intervention with iStent technology helps stabilize IOP and plays a critical role in preserving vision and preventing disease progression.

Globally, iStent technology has been widely adopted, with over 3 million implants performed worldwide.

Commenting on this achievement, Dr. Azad Gaurav said:

"The introduction of iStent Inject® W in Lucknow marks a new era in glaucoma management for our region. Early-stage glaucoma patients now have access to a minimally invasive option that not only controls IOP effectively but also reduces their dependence on lifelong medications. Our goal is to preserve vision with the least possible disruption to patients’ daily lives."

Adding to this, renowned glaucoma specialist Dr. Rajat Dhsai remarked:

"Micro-invasive glaucoma surgery, particularly with technologies like iStent Inject® W, is transforming the way we approach glaucoma treatment. It bridges the gap between medical therapy and conventional surgery, offering a safer and patient-friendly solution for early intervention. The adoption of such advanced technologies in cities like Lucknow is a significant step toward improving glaucoma outcomes across India."

The first patient treated with this technology at Prakash Netra Kendra has shown encouraging early outcomes, including stable intraocular pressure and reduced reliance on medications, underscoring the effectiveness of the procedure.

The successful introduction of iStent Inject® W at Prakash Netra Kendra reinforces the institution’s commitment to bringing world-class ophthalmic innovations to Uttar Pradesh. It also ensures that patients in Lucknow and surrounding regions can now access advanced glaucoma care without the need to travel to metropolitan centers.

About Prakash Netra Kendra

Prakash Netra Kendra, Lucknow, is a leading eye care center dedicated to delivering comprehensive and advanced ophthalmic services. With a focus on innovation, precision, and patient-centric care, the center continues to adopt the latest technologies to improve clinical outcomes and enhance patient quality of life.

Media Contact:
Prakash Netra Kendra
Gomti Nagar- NH-II, VipulKhand-IV, Gomtinagar, Lucknow 226010
pnk.tpa@gmail.com
info@pnkeyecare.com
0522 424 2164
Contact Us

Lucknow, Uttar Pradesh — In a landmark development for ophthalmic care in North India, Dr. Azad Gaurav has successfully performed the first iStent Inject® W procedure in Lucknow and the state of Uttar Pradesh at Prakash Netra Kendra, Lucknow. This milestone introduces a globally recognized, minimally invasive glaucoma surgery (MIGS) to patients in the region, offering a safer and more effective solution for early-stage glaucoma management.

The iStent Inject® W is an advanced micro-invasive implant designed to reduce intraocular pressure (IOP) by improving the eye’s natural fluid outflow. Particularly beneficial for patients with mild to moderate primary open-angle glaucoma (POAG), the procedure is performed through a minimally invasive approach, ensuring faster recovery, reduced surgical risk, and improved patient comfort.

This innovative treatment provides patients with the potential to significantly reduce—or even eliminate—their dependence on long-term anti-glaucoma medications, which are often associated with compliance challenges and side effects. Early intervention with iStent technology helps stabilize IOP and plays a critical role in preserving vision and preventing disease progression.

Globally, iStent technology has been widely adopted, with over 3 million implants performed worldwide.

Commenting on this achievement, Dr. Azad Gaurav said:

"The introduction of iStent Inject® W in Lucknow marks a new era in glaucoma management for our region. Early-stage glaucoma patients now have access to a minimally invasive option that not only controls IOP effectively but also reduces their dependence on lifelong medications. Our goal is to preserve vision with the least possible disruption to patients’ daily lives."

Adding to this, renowned glaucoma specialist Dr. Rajat Dhsai remarked:

"Micro-invasive glaucoma surgery, particularly with technologies like iStent Inject® W, is transforming the way we approach glaucoma treatment. It bridges the gap between medical therapy and conventional surgery, offering a safer and patient-friendly solution for early intervention. The adoption of such advanced technologies in cities like Lucknow is a significant step toward improving glaucoma outcomes across India."

The first patient treated with this technology at Prakash Netra Kendra has shown encouraging early outcomes, including stable intraocular pressure and reduced reliance on medications, underscoring the effectiveness of the procedure.

The successful introduction of iStent Inject® W at Prakash Netra Kendra reinforces the institution’s commitment to bringing world-class ophthalmic innovations to Uttar Pradesh. It also ensures that patients in Lucknow and surrounding regions can now access advanced glaucoma care without the need to travel to metropolitan centers.

About Prakash Netra Kendra

Prakash Netra Kendra, Lucknow, is a leading eye care center dedicated to delivering comprehensive and advanced ophthalmic services. With a focus on innovation, precision, and patient-centric care, the center continues to adopt the latest technologies to improve clinical outcomes and enhance patient quality of life.

Media Contact:
Prakash Netra Kendra
Gomti Nagar- NH-II, VipulKhand-IV, Gomtinagar, Lucknow 226010
pnk.tpa@gmail.com
info@pnkeyecare.com
0522 424 2164

Latest post

India’s Trusted Financial Service Platform: MyCrediBro Simplifying Access to Credit with Transparency and Value

Game-Changer in Women’s Health: Earmark Organic’s “India’s First Hemp Balance 360” Directly Challenges the Industry

Global Leadership Summit – Vision 2047 to be held at Yashobhoomi Convention Centre on 18-19 July 2026

Popular Posts

From OYO to alt.f coworking: The Founders of Turning One Building into a Revenue-Generating Engine, Meet Ritesh Agrawal on Shark Tank (847)

AUM YogaFerma Cryptocurrency for Organic Farming: How Kumbh Mela Changed a Russian Farmer’s Life (720)

Strides Software Solutions Completes Primary and Secondary Fundraise, Welcomes New Investors (672)

Talbiya Umrah Pvt. Ltd. | India’s Top Hajj and Umrah Company (562)

SuperHumanRace and CREDAI Maharashtra Join Forces to Launch Regional Emissions Inventories for Real Estate (388)

Stay Connected

Category: Health

Revolutionizing Glaucoma Care in Uttar Pradesh: First iStent Inject® W Procedure Successfully Performed in Lucknow

Rotary Club of Madras South Launches “பாதம் காப்போம்” Diabetic Foot Care Initiative at VHS, Chennai

Thind Eye Hospital Expands to Ludhiana, Bringing Advanced Super-Specialty Eye Care to Punjab’s Largest City

Doctor-Founded Episenz Skin Science Emerges with a Preventive Skincare Vision for the Next Decade of Dermatology-Led Consumer Health

Premas Life Sciences Partners with Bruker Spatial Biology to Strengthen Advanced Tissue Research in India

Survivors of online sexual abuse in the US face legal gaps and inaction by tech companies, new report finds

HARLEY of LONDON India to Launch Global Centre of Excellence for Health, Wellness & Lifestyle in Chandigarh

Meducination and Ujala Cygnus Launch Clinical Observership Programs to Strengthen Practice-Readiness of Medical Graduates

RCMS Donates Advanced Pediatric Ventilators to Institute of Child Health, Egmore

Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease

Popular Post

From OYO to alt.f coworking: The Founders of Turning One Building into a Revenue-Generating Engine, Meet Ritesh Agrawal on Shark Tank (847)

AUM YogaFerma Cryptocurrency for Organic Farming: How Kumbh Mela Changed a Russian Farmer’s Life (720)

Strides Software Solutions Completes Primary and Secondary Fundraise, Welcomes New Investors (672)

Talbiya Umrah Pvt. Ltd. | India’s Top Hajj and Umrah Company (562)

SuperHumanRace and CREDAI Maharashtra Join Forces to Launch Regional Emissions Inventories for Real Estate (388)

Weather

Newsletter